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Abstract – Bovine viral diarrhea virus (BVDV), a Flaviviridae pestivirus, is arguably one of the most
widespread cattle pathogens worldwide. Each of its two genotypes has two biotypes, non-cytopathic (ncp)
and cytopathic (cp). Only the ncp biotype of BVDV may establish persistent infection in the fetus when
infecting a dam early in gestation, a time point which predates maturity of the adaptive immune system. Such
fetuses may develop and be born healthy but remain infected for life. Due to this early initiation of fetal
infection and to the expression of interferon antagonistic proteins, persistently infected (PI) animals remain
immunotolerant to the infecting viral strain. Although only accounting for some 1% of all animals in regions
where BVDVis endemic, PI animals ensure the viral persistence in the host population. These animals may,
however, develop the fatal mucosal disease, which is characterized by widespread lesions in the
gastrointestinal tract. Cp BVD virus, in addition to the persisting ncp biotype, can be isolated from such
animals. The cp viruses are characterized by unrestrained genome replication, and their emergence from the
persisting ncp ones is due to mutations that are unique in each virus analyzed. They include recombinations
with host cell mRNA, gene translocations and duplications, and point mutations. Cytopathic BVD viruses
fail to establish chains of infection and are unable to cause persistent infection. Hence, these viruses illustrate
a case of ‘‘viral emergence to extinction’’ – irrelevant for BVDVevolution, but fatal for the PI host.
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1. INTRODUCTION
The Websters New World Dictionary
explains the meaning of the verb ‘‘emerge’’ as
(i) ‘‘to rise from a surrounding ﬂuid,’’ (ii) to
come forth into view, to become visible, to
become apparent or known, and (iii) to develop
or evolve as something new. As regards viruses,
the most frequent usage of ‘‘emerging’’ follows
the latter explanation; even though, in many
cases version (ii) would seem to be more appro-
priate, considering that emerging viruses may
have been present for a long time in geograph-
ically remote areas before becoming known by
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40, 66, 88]. In this context, labeling bovine viral
diarrhea virus (BVDV) as ‘‘emerging’’ may
seem to be out of place for a number of reasons.
Firstly, this virus is by no means new, the virus
having ﬁrst been described in 1946 [72], and
with over 2 500 citations listed in PubMed.
Secondly, BVDV may well be the most wide-
spread virus in bovines, being present in cattle
populations all over the world [34, 37]. How-
ever, what justiﬁes inclusion of this virus in this
list is the emergence of an altered biotype that
results in a spectacular and invariably lethal dis-
ease referred to as ‘‘mucosal disease’’.
2. BVDV: A PESTIVIRUS OF
THE FLAVIVIRIDAE FAMILY
Pestiviruses are a genus of the family Flavi-
viridae, whose name is derived from the yellow
fever virus (from ﬂavus, the skin color of
humans suffering from jaundice). Yellow fever
virus is the type species of the genus ﬂavivirus.
Other medically important representatives of
this genus include tick-borne encephalitis virus
and Japanese encephalitis virus [54]. The best
known representative of the genus hepacivi-
rus is hepatitis C virus which infects some
120–170 million humans worldwide [2, 84]
and is a leading cause of liver cirrhosis and
hepatocellular carcinoma [21]. The Flaviviridae
are similar in their genetic organization and
basic molecular biology (Fig. 1). The genes of
the structural proteins are located at the 50 end
of the approximately 10–15 kb positive single
strand RNA genomes, followed in the 30 direc-
tion by the genes encoding the nonstructural
proteins. Translation of the genome is started
by cap-independent, IRES (internal ribosome
entry site)-mediated binding to ribosomes
(pestivirus or hepacivirus) or by cap-dependent
Figure 1. Genome organization of viruses from the genera ﬂavivirus, pestivirus, and hepacivirus within the
family Flaviviridae. The length of the viral RNA genomes are illustrated on top of each panel, and
homologous regions between the genomes are indicated. Only the RNA of ﬂaviviruses is capped at the
50-end. The processing of the polyprotein into the individual structural and nonstructural proteins is
indicated below. All the core proteins and the NS4A of ﬂaviviruses are further processed at their C-terms
(white boxes). For cytopathic pestiviruses, enhanced expression of NS3 is observed, whereas the uncleaved
form, NS2-3, predominates in non-cytopathic pestiviruses. ns, non-structural; UTR, untranslated region.
(A color version of this ﬁgure is available at www.vetres.org.)
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pro: The phylogenetic tree that
represents the genetic relationship of pestivirus strains was constructed from the complete N
pro coding
sequences except for the two strains Aydin/04 (EU930014) and Burdur/05 (EU930015). However, since
constructing the tree with all sequences shortened to 420 nucleotides did not change the basic structure of the
tree(datanotshown),weincludedthesestrainsintheanalysis.SequenceswereobtainedfromGenBank and the
sequences of the Swiss BDV strains CH-BD3 (GU244490) and CH-BD4 (GU244489) were described by
C.Reichert
1.The analysiswascomputedusingtheprogramsincludedintheGCGsoftware packageasPILEUP
for the multiple sequence alignment and PAUP for calculating the distances by the Kimura 2-parameter
method and constructing the tree according to the neighbor-joining method. Branch numbers (italics) indicate
the percentage of 1000 bootstrap replicates. Only bootstrap values over 95 are shown. Branch lengths
are proportional to genetic distances, and the bar shown indicates 0.1 substitutions per site. The classiﬁcation of
the various pestiviruses was composed according to [23, 71, 94]. Virus strains within the ‘‘BVDV-3’’ group
were named according to [56, 57], but they had previously also been labeled as ‘‘unclassiﬁed’’ [90]
or ‘‘atypical’’ [55]. Virus strains within the chamois group in this paper were sometimes assigned to BDV-4
[3, 61, 71, 78, 93, 99], whereas the Tunisian isolates SN1Tand BM01 were recently labeled as TSV (Tunisian
sheep virus, [57]). (A color version of this ﬁgure is available at www.vetres.org.)
1 Reichert C., Infektion von Ka ¨lbern, Schafen und Ziegen mit Border-Disease-Virus, Veterinary Doctoral
thesis of the Vetsuisse Faculty, University of Zurich, Switzerland, 2009.
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genomes contain a single open reading frame
w h i c hr e s u l ti np r o t e i n so f3 0 0 0t o4 0 0 0
amino acids. Cleavage of the polyprotein into
the mature individual proteins is by virally and
host-encoded proteases (for a review, see [54]).
Pestiviruses infect even-toed animals (order
Artiodactyla). These hosts are quite diverse
and, in addition to domestic animals such as
cattle, sheep, and old and new world camelids,
include feral animals such as antelopes and
deer (Fig. 2). Since the search for pestiviruses
in feral animals is not a research priority of
granting agencies, it seems likely that the spec-
trum of pestiviruses may be considerably
wider than those known to date, and thus other
strains will be found in the near future. An
example illustrating this point is the recently
discovered Bungowannah virus. Although this
virus was detected in pigs suffering from myo-
carditis, its origin is unknown and may well be
found in wildlife [24, 43]. It remains unknown
whether these emerging strains cause various
diseases in their host animals or whether they
are indirectly involved due to the immunosup-
pressive effect of pestiviruses [12, 20, 76, 79].
Notably, a number of BVDV strains were
identiﬁed as being responsible for contamina-
tion in cell cultures, e.g., strain HoBi [83]o r
CH-KaHo/cont [90], both found to be similar
Figure 3. Phylogenetic analysis and classiﬁcation of BVDV based on N
pro: The phylogenetic tree that
represents the genetic relationship of BVDV strains was constructed from 349 nucleotides of the N
pro
coding sequences. The genetic analysis was calculated and the ﬁgure prepared as described for Figure 2.
The sub-genotype BVDV type-1l was assigned according to [36, 39]. The strains So CP/75 and TR8/TR16,
which were also labeled as BVDV-1l by [5, 102] and [104], were renamed as BVDV type-1n and -1p,
respectively. BVDV sub-genotypes m, n, and o were named as in [70]. All other groups were assigned as
suggested by [97, 98]. (A color version of this ﬁgure is available at www.vetres.org.)
Vet. Res. (2010) 41:44 E. Peterhans et al.
Page 4 of 14 (page number not for citation purpose)to virus strains isolated in Brazil or Thailand
[89, 90], or strain PG2 (Fig. 2)w h i c hw e
found in bovine cells prepared in Kenya with
local serum [10]. Thus, it would come as no
surprise if many laboratories working with cell
cultures of ruminants unwittingly propagate
pestiviruses (see, e.g., [4, 7, 62, 96], and
unpublished observation). The taxonomy of
pestiviruses is constantly changing, partly
because of the discovery of new pestiviruses,
but also because the criteria for the allocation
of species status and division in subgroups
within a given species (Fig. 3) are not used
uniformly [41, 57, 58]. Currently, the pestivi-
ruses include four ofﬁcial species
2 (Fig. 2),
BVDV-1 and -2, classical swine fever virus
(CSFV) and border disease virus (BDV), and
one tentative ﬁfth species represented by only
two strains, Giraffe-1 (H138) and PG2 [10].
3. PERSISTENT INFECTION WITH BVDV,
THE EMERGENCE OF CP BVDV, AND
MUCOSAL DISEASE
For recent reviews on BVDV, see [54, 77,
82]. Although genetically and antigenically
diverse (Fig. 3), BVDV type-1 and BVDV
type-2 have in common the existence of two
biotypes that are differentiated according to
either inducing death in cultured cells (cyto-
pathic biotype, cp), or failing to induce cell
death (non-cytopathic biotype, ncp). However,
it is important to note that the cytopathogenicity
of a pestivirus does not correlate with its viru-
lence, since most virulent, i.e. disease causing,
strains are of the ncp biotype [77]. The two
biotypes are closely associated with two funda-
mentally different forms of infection in cattle –
either transient or persistent. BVD viruses of
the cp biotype emerge from ncp ones exclu-
sively in persistently infected (PI) animals and
are invariably associated with a lethal outcome
of persistent infection, referred to as mucosal
disease (Fig. 4). Some 60% of animals living
in regions where BVDV is endemic and not
inﬂuenced by control measures are transiently
infected at some stage of their lives. These ani-
mals may suffer from mild diarrhea or respira-
tory symptoms or else show no signs of
infection at all. After seroconversion, the ani-
mals are protected from re-infection for life.
Persistent infection is initiated in embryos from
the second to fourth of the 9.5 months of devel-
opment. In most cases, virus reaches the
embryo when pregnant animals undergo a tran-
sient infection, but virus may also be transmit-
ted to the fetus by a pregnant PI dam. Due to
the early period of development, the immature
immune system of the fetus fails to mount an
adaptive immune response to the virus but
develops immunotolerance to the infecting viral
strain. Only ncp, but not cp, biotypes of BVDV
are capable of establishing and maintaining per-
sistent infection. This difference is associated
with a different interaction of the two biotypes
with the innate immune response against viral
infection, which is active from the very begin-
ning of gestation. Interferon (IFN) type-I (also
called IFN-a/b) is a key player in the antiviral
defense of the innate immune system that is
active before the adaptive immune system kicks
in with an antigen-speciﬁc defense. Ncp BVD
viruses fail to induce IFN type-I in various
types of cultured cells whereas infection with
cp virus readily triggers IFN generation [75].
The role of the innate immune response became
more prominent when it was recognized that
the innate immune system may not be as unspe-
ciﬁc as originally assumed [100]. It detects ele-
ments that are common to one or several classes
of infectious agents, referred to as ‘‘pathogen-
associated molecular patterns’’ (PAMP) or
‘‘danger signals’’. Such PAMP are recognized
by a limited repertoire of germ-line encoded
‘‘pattern recognition receptors’’ (PRR), such
as Toll-like receptors (TLR), RIG-I-like recep-
tors (RLR), or NOD-like receptors (NLR)
[65]. These PRR are located at the cell surface,
in endosomes, or intracellularly, i.e., at sites that
are crucial for the early detection of pathogens.
The recognition of pathogens by the innate
immune system is a prerequisite for an adaptive
immune response to occur. Dendritic cells (DC)
in particular have been recognized to play a
central role in primary immune responses,
and they also initiate and regulate adaptive
2 http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/fs_ﬂavi.
htm#Genus2
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an array of cytokines, the most prominent one
beingIFNtype-I,linkingtheinnateandadaptive
arms of the immunesystem [11].Thisthenleads
to up-regulation of MHC expression, presenta-
tion of co-stimulatory molecules, efﬁcient
activationandcross-primingofT-cells,andstim-
ulation of humoral immunity [25, 51, 91]. In
addition, it recently became evident that the
cooperation between the innate and adaptive
immune system also acts reciprocally, i.e. the
adaptive mechanisms have an impact on the
innate immune responses [73, 105].
During replication, both biotypes of BVDV
express the N-terminal protease N
pro and the
glycoprotein E
rns (Fig. 1). N
pro expressed by
virus-infected cells targets the transcription fac-
tor IRF-3 for proteasomal degradation indepen-
dently of its protease activity [8, 31, 35, 46],
thereby inhibiting IFN generation. In addi-
tion, the structural protein E
rns is also released
from infected cells, and by its intrinsic RNase
Figure 4. Persistent versus transient infections: BVDV causes two types of infection in vivo. Infection of a
seronegative animal with BVDVof either biotype leads to a transient (acute) infection that usually causes no
or mild clinical symptoms. The virus will be eliminated by the humoral and cellular immune response that
will protect the animal from further infections. In contrast, infection with ncp, but not cp, BVDV between
the second and fourth month of gestation may lead to persistent infection of the fetus. Infection later in
gestation may lead to abortion, malformation, or to the birth of normal, immunocompetent calves. PI calves
are immunotolerant to the infecting BVDV strain. These animals are born antibody negative and shed large
amounts of virus during their entire lifetime. If the persisting ncp virus mutates into a cp biotype or if the
PI animal is superinfected with an antigenically related cp virus, the PI calf will succumb to the lethal
mucosal disease. (A color version of this ﬁgure is available at www.vetres.org.)
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induced by extracellular viral ss- and dsRNA
even in uninfected cells [38, 60, 68]. However,
cp BVD viruses were shown to produce more
double-stranded RNA than ncp biotype viruses
[68, 103]. The high concentration of this PAMP
signaling viral infection might overwhelm the
efﬁciency of the N
pro-a n dE
rns-mediated inhibi-
tion of IFN production that, however, sufﬁces
in ncp BVD virus-infected cells. Since IFN is
an antiviral defense mechanism present from
the earliest period of intrauterine development,
the evasion of this innate immune response
may well contribute to the establishment of per-
sistent infection by BVDV. Indeed, cp BVD
virus has been shown to trigger IFN generation
in the developing fetus whereas the ncp biotype
failed to do so, in line with the capacity of the
latter to establish persistent infection [18]. Inter-
estingly, immunologically naı ¨ve and virus-free
animals infected postnatally produce IFN
type-I in response to infection with both bio-
types of BVDV [19].
Fetuses infected during the critical period in
utero may develop and be born normal. How-
ever, they continue to produce and shed large
amounts of virus throughout their lives. In such
animals, virus can be detected primarily in all
types of white blood cells in lymphatic tissues
a n db l o o db u ta l s oi ns k i na n dh a i rr o o t s .I n
fact, virus can be isolated from epilated hair,
and viral RNA can be detected on the skin sur-
face (Bachofen
3 and Peterhans, in preparation).
Clinically, many PI animals may show no, or
only mild, signs of infection, including intermit-
tent diarrhea and pneumonia. In addition, as
indicated by the increased frequency of infec-
tions, animals may be immunosuppressed and
some animals also show growth retardation.
These signs of persistent infection are particu-
larly interesting because they have been postu-
lated to be due to chronic IFN production to the
persisting BVD virus [85, 87]. However, some
PI animals may even be selected for breeding
and give birth to calves that will also be PI,
indicating that infection may be innocuous in
these animals.
After months or even years, the persistent
infection may take a lethal course, characterized
by bloody diarrhea, fever and in some cases,
lesions in the mouth and interdigital clefts. In
postmortem analysis, ulcera are found in differ-
ent parts of the digestive tract, especially in the
Peyer’s patches. From animals suffering from
this ‘‘mucosal disease’’, a cp BVD virus can
be isolated in addition to the persisting ncp bio-
type. Since the ncp and cp BVDV strains iso-
lated from an individual animal suffering from
mucosal disease are antigenically and geneti-
cally very closely related, they are referred to
as a ‘‘virus pair’’ [15]. Indeed, in PI animals,
the cp biotype arises from its persisting ncp
counterpart by genomic changes, e.g., point
mutations or non-homologous RNA recombi-
nations leading to the insertion of viral or cellu-
lar sequences (for reviews, see [45, 54, 63, 82]).
The latter was shown to occur either by
replicative template switching of the viral
RNA-dependent RNA polymerase, or by viral
replication-independent RNA recombination
[29]. Genetic analysis of a large variety of
BVD virus pairs revealed that the enhanced
production of the nonstructural protein NS3 is
the most important feature common to all cp
strains characterized to date. The increase in
NS3 synthesis correlates with the high rate of
viral RNA synthesis and the induction of cell
death by apoptosis in cell culture. Interestingly,
cp ﬁeld strains of BDVand CSFV, in contrast to
BVDV, were rarely identiﬁed [63], and cp
strains of CSFV were found to be cp DI parti-
cles that required the presence of an ncp CSFV
helper virus ([30] and references therein). Such
DI particles lacking most parts of the viral gen-
ome coding for the structural proteins, NS2 and
p7, were similarly described in cp viruses
isolated from cattle with mucosal disease [9].
One common modiﬁcation of the BVDV
genome to yield a cp biotype is the insertion
of cellular gene fragments. For example, the
insertions of ubiquitin- or ubiquitin-like genes
occur rather frequently, which may or may
not be accompanied by duplications of the viral
genome including the NS3 region. Notably, the
Osloss strain contains an insertion of a single
3 Bachofen C., BVD Virus in persistent inﬁzierten
Tieren: Bedeutung der intakten Haut als Infektions-
quelle, Veterinary Doctoral thesis of the Vetsuisse
Faculty, University of Bern, Switzerland, 2002.
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out any duplication of viral sequences. Despite
the fact that uncleaved NS2-3 is required for
virus particle assembly [1, 67], this insertion
within the NS2-3 gene of BVDV Osloss strain
obviously does not impair the production of
infectious virus particles.
Another type of recombination with cellular
genes is the insertion of the Jiv (J-domain pro-
tein interacting with viral protein) RNA or a
fragment thereof (called Jiv90) in the NS2
[80]o rt h eN
pro region [42, 69] of the viral gen-
ome. Overexpression of this Jiv protein induces
the cleavage of NS2-3 and thus leads to the
appearance of a cytopathic effect in vitro.
Intriguingly, the group of N. Tautz revealed that
Jiv activates the autoprotease activity of NS2 in
a stoichiometric amount [47, 49] and, impor-
tantly, that this autoprotease activity within
NS2 is even essential for the replication of
ncp BVDV [48]. Thus, NS3 is required for
the replication of BVDV, and cannot be
replaced by uncleaved NS2-3. Due to the very
limited amount of Jiv present in the host cell,
NS2-3 cleavage in ncp BVDV-infected cells is
temporally controlled and occurs to only a
reduced extent (often only detectable at early
time points post-infection), preventing the
appearance of cytopathic effect. In ncp CSFV
infections, NS3 expression can be observed
also at later time points, but NS2-3 seems to
be similarly controlled by the presence of cellu-
lar Jiv [30, 67], and Jiv overexpression strongly
increases NS2-3 cleavage and leads to a cp bio-
type of CSFV [30].
Yet another type of genome modiﬁcation
found in cp biotypes consists of duplications
andadditionalinsertionsofBVDviralsequences.
Thus, various duplications of viral sequences
including the NS3 region, insertion of the auto-
protease N
pro upstream of NS3, or insertions into
NS2 of sequences from the NS4B-NS5A-NS5B
region of the genome
4 [17] were described.
All these various RNA recombinations and
mutations seem to make NS2-3 cleavage Jiv-
independent, thus uncoupling viral replication
from the control by this essential host factor.
This occurs by (i) activating the NS2 autopro-
tease by supplying additional Jiv by the viral
genome, (ii) inducing conformational changes
within NS2 stimulating its activity in the
absence of Jiv, or (iii) attracting other proteases
of the host to excise NS3. The increased synthe-
sis of NS3 then leads to enhanced viral RNA
and protein production and to apoptosis.
The fact that BVD viruses of the cp biotype
arise from ncp ones also explains a feature of
mucosal disease that puzzled virologists when
they were unsuccessfully trying to reproduce
mucosal disease by inoculation of cp BVDV
in immunologically naı ¨ve and BVDV-free ani-
mals. Thus, such animals readily mount an
immune response to the cp virus, mostly with-
out showing any sign of infection. In fact, many
of the BVDV live vaccines are simply viral
strains of the cp biotype [28, 32, 64]. In contrast
to the control of infection with cp BVDV in
these animals, there is a continued uninhibited
replication of the cp biotype emerging by muta-
tion from its persisting and immunologically
tolerated ncp counterpart, which explains the
invariably fatal outcome of mucosal disease.
4. EVOLUTION OF BVDV: THE ROLE
OF PERSISTENT INFECTION AND
THE EMERGENCE OF CP BIOTYPES
Due to the high error rate and missing cor-
rection mechanism of the RNA-dependent
RNA polymerase and, in the case of retrovi-
ruses such as human immunodeﬁciency virus
(HIV), reverse transcriptase, RNA viruses dis-
play a high genetic plasticity, which is addition-
ally increased by RNA recombination. As
exempliﬁed during persistent infection with
HIV, the immune response favors the emer-
gence of novel mutants that are capable of
escaping the immune pressure exerted on the
existing spectrum of viral variants. Over time,
the continued emergence of new mutants
changes the quasispecies present in the infected
patient. An additional important element inﬂu-
encing viral evolution is viral transmission. In
the case of HIV, it was estimated that approxi-
mately 80% of productive infections were the
result of successful transmission of a single
virus or a single virus-infected cell (reviewed
4 Antunes A., unpublished observation.
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very limited spectrum of variants transmitted
may further contribute to the rapid viral evolu-
tion observed within individual chains of infec-
tion. Compared to this scenario, the evolution
of BVDV shows marked differences. As
described above, PI animals are generated as a
result of transient infection of pregnant cows,
or are born to PI cows. We found a remarkable
sequence conservation between PI animals and
their PI calves, with the presence of a wide
spectrum of variants that contrasts with the very
narrow spectrum transmitted in HIV. The viral
quasispecies did not markedly change over a
period of one year in PI animals
5. Furthermore,
the nucleotide sequences of BVDV in PI ani-
mals living in the same herds were found to
be very similar ([33, 36, 95], and unpublished
observation). One obvious difference in the
evolution of HIV versus BVDV is the different
role the immune system plays in PI hosts. In
contrast to HIV, BVDV is subject to immuno-
tolerance during persistent infection, which is
established early in gestation. This suggests that
the immunotolerance may be speciﬁc for the
BVD viral spectrum that was present during that
period. The immune system may not only toler-
ate the original quasispecies of viruses, but in
fact may prevent the emergence of antigenic
variants that are outside of this spectrum. HIV
and BVDV also differ in important aspects of
transmission to new hosts. Thus, humans
infected with HIV may travel the world and
transmit virus to multiple partners, which
increases the spread of virus to geographically
distant regions. In contrast, most bovines live
in individual, separate herds. The frequency of
contact with animals of other herds depends
mostly on management procedures. We
observed an interesting example of this when
we analyzed BVD viruses present in the Swiss
cattle population. The different subgroups of
BVDV type-1 (Fig. 3) showed a geographically
randomized distribution in the entire cattle pop-
ulation,withnoevidenceofemergenceorexclu-
sion of any given subgroup of BVDV [5].
This correlated with the management practice
of annual transhumance in the Alps of about
one third of the entire cattle population. Accord-
ing to old traditions, heifers originating from
different herds and regions are kept in large
herds during the summer months. In this age
group of animals, herd immunity is lower than
average, with many of the animals early in their
ﬁrst gestation and susceptible to infection.
Before the start of the current Swiss BVDV
eradication program there was no screening of
animals for BVDV status before the summer
grazing period. This was a signiﬁcant risk factor
for acute infection of heifers with BVDV and
persistent infection in their offspring born in
the following winter and early spring [13, 44,
81, 86]. The emergence and rapid spread of
highly virulent BVDV type-2 strains during
the late 1980s and early 1990s in Canada and
the USA differ markedly from this stable ende-
mic pattern found in Switzerland. Most likely,
these strains could spread widely because herd
immunity against BVDV type-2 was low or
absent, with no cross-protection by immunity
to BVDV type-1 [74]. Similarly, various
national and regional eradication programs
without the use of vaccination were success-
fully implemented in Europe [53]. However,
this will lead to antibody-negative, highly sus-
ceptible cattle populations, and strict biosecurity
measures will be required to prevent that
BVDV will become a ‘‘re-emerging’’ virus in
these countries.
In contrast to the stable situation seen with
the ncp biotype in a country where BVDV
type-1 is endemic and BVDV type-2 is absent
as described above, cp BVD viruses may
indeed be viewed as ‘‘emerging’’, not least
because these viruses pop up with a spectacular
disease with a lethal outcome. Importantly,
BVD viruses of this biotype, however, do not
cause persistent infection, which would be
required to maintain the virus in the host popu-
lation, nor do they spread in the population to
any signiﬁcant extent. A very limited spread
may occasionally be observed when additional
animals persistently infected with a homolo-
gous virus strain succumb to mucosal disease
in a herd due to superinfection by the cp virus
shed by the index case of mucosal disease.
However, the overall prevalence of PI animals
is approximately 1% only, and clustering of
5 Manuscript in preparation.
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cp BVD viruses may be labeled as ‘‘emerging
viruses doomed to extinction whenever they
appear’’. In support of this interpretation,
genetic analysis showed that the mutations lead-
ing to the cp biotype are unique in every cp
BVD virus analyzed to date [9, 45, 82].
BVD viruses of the cp biotype may be
viewedasindicatorsofthegeneticplasticitytyp-
ical of RNA viruses in general. However, since
there is no evidence to suggest that BVDV
may differ in their genetic plasticity from other
RNA viruses, the emergence of cp biotypes of
BVDV causing mucosal disease may indeed
be a very insensitive indicator indeed. Thus,
on the one hand, the average age at which PI
animals spontaneously develop mucosal disease
is 6–18 or 24 months[14,16,26,92],whichcor-
responds well with the fact that mucosal lesions
are mainly detected in older animals [6]. On the
other hand, PI animals experimentally infected
with homologous cp BVDV were shown to
develop mucosal disease within a few weeks
post-infection [27, 59]. Assuming that a PI ani-
mal may generate 10
11 to 10
12 virions per day
[50] and that only 1 to 10% will be incorporated
into infectious virusparticles, it canbe estimated
thatsome10
14–10
17viralgenomecopiesmaybe
requiredbeforea cp biotype capable ofinducing
mucosal disease may emerge. The apparent low
frequency of the emergence of successful cp
BVD viruses (i.e. capable of causing mucosal
disease)canbeexplainedbythenumerousfunc-
tional constraints these viruses must overcome.
Among those are the requirements to be of the
cp biotype, immunologically tolerated and of
high ﬁtness resulting in a buildup in numbers
that explains the widespread destruction of lym-
phoid tissue that is typical of mucosal disease.
5. CONCLUSION
Mucosal disease is a rare example that sig-
nals viral evolution associated with a change
of biotype leading to the death of the affected
animal and, ultimately, also to the extinction
of the cp virus that caused the fatal disease.
Hence, the emergence of cp BVD viruses in
PI animals reﬂects an accident that remains
without consequences for viral evolution. The
paradoxical discrepancy between the apparent
genetic stability of ncp BVDV, on the one hand,
and the dramatic emergence of cp biotype
viruses, on the other hand, can both be
explained by immunotolerance. Thus, immuno-
tolerance adds the ncp BVD virus to the ‘‘self
repertoire’’ of its host early in embryogenesis.
Continued immunotolerance may prevent the
appearance of antigenic variants that might vio-
late this tolerance over several generations of PI
animals. This may be an important aspect of the
preservation of individual viral strains in the
cattle population, and implies that the large
variety of BVDV strains observed today
evolved over a long period of time. In contrast,
the unrestricted multiplication of the cp biotype
in PI animals may only be possible because the
cp BVD virus is derived from the parental per-
sisting ncp strain and thus is immunologically
tolerated. As a unique aspect among all persis-
tent viral infections known to date, the immune
system may thus both preserve the virus and
simultaneously enable the same virus to kill
its host after it has undergone mutations that
result in the loss of its ability to replicate in
its host cells without triggering apoptosis.
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